Chevron and Occidental Petroleum are two oil stocks garnering a lot of attention these days, primarily because both are held in the esteemed portfolio of Warren Buffett.
But a closer examination of them both and their rivals suggests another oil stock may be a much better deal right now. So, is it time to buy?
Warren Buffett has spent his life building Berkshire Hathaway, a firm he describes as a mosaic that will never be completed. You would think that having put so much of his heart and soul into painting this canvas that he would surely advise his beneficiaries to cling on to Berkshire shares with a tight grip after he has passes on.
» Read more about: 1 ETF Buffett Prefers Over His Own Berkshire »
If you look down the list of dividend stocks that Warren Buffett’s Berkshire Hathaway owns, the highest yielding one will surprise you and it’s not apparent at first glance.
A cursory examination of his portfolio would suggest that the highest paying dividend stock is Citigroup, which pays a 4.3% yield and represents a 0.7% stake.
» Read more about: Buffett’s Top Dividend Stock Will Surprise You »
How would you identify the #1 stock in Buffett’s portfolio? Is it the fastest growing stock, the biggest by market cap, the largest by weighting or the most undervalued?
We decided to pick the latter for this article and do a deep dive into all his positions to figure out which one is most undervalued across his whole equity portfolio.
It’s rare to find an $8.6 billion market capitalization firm that is severely undervalued. Once you get to the billion dollar company level, analysts and investors are astutely aware of what an enterprise is worth as they run quarterly financial models to assess value.
But every once in a while a deal crops up,
» Read more about: 1 Unusual Stock Trading at Rock Bottom Levels »
Believe it or not you’re about to get a very precise answer to the question when will the market top but, before the entree, a little appetizer.
As we enter year-end, the market has a lot of bullish forces driving it higher, and should continue to support the markets into the new year.
» Read more about: Market Commentary: When Will The The Market Top? »
Bristol Myers Squibb (BMY) poses something of a conundrum to investors at the moment. On the one hand, the share price has dramatically underperformed the market, leading to concerns that further declines are on the horizon. And on the other hand, the valuation is starting to look really attractive to bargain hunters.
So,
» Read more about: Down 30%, Is It Time To Buy This Pharma Giant? »
Molina Healthcare is not widely known among investors but that may be about to change following 15 quarters straight of year-over-year revenue growth and a member base that has grown to approximately 5.2 million across 20 states as of the most recent quarter.
Strategic moves like acquiring My Choice Wisconsin,
» Read more about: 1 Undervalued Healthcare Stock Flying Under The Radar »
Despite his fame as Warren Buffett’s right-hand man, Charlie Munger, who recently passed away at 99, maintained a remarkably low public profile, letting his vast wisdom and sharp wit speak through his investments and rare, yet profound, public statements.
Charlie was renowned for his role as the vice chairman of Berkshire Hathaway and his partnership with Warren Buffett,
» Read more about: Market Commentary: How Charlie Got So Rich »
Famously, it’s been said that the restaurant business is a horrible one. You have to pay the rent, the staff, the food costs, and keep the lights on, and when you’re done with all that you have to hope your menu is right, the chefs show up each day, and the customers like the food.
» Read more about: Market Commentary: 1 Food Stock That Defies All Odds »